ArticleArchives of microbiology2026
Novel antibiofilm strategies against Pseudomonas aeruginosa NG4 using oleic acid and indole-3-butyric acid.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quorum-quenching enzymes as next-generation antibiofilm therapeutics: mechanisms, applications, and future perspectives.World journal of microbiology & biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biofilm-associated infections caused by Pseudomonas aeruginosa are highly tolerant to conventional antibiotics, driving the search for novel agents capable of disrupting biofilm formation and associated virulence traits. In this study, the antibiofilm, anti-motility, and growth inhibitory effects of indole-3-butyric acid (IBA) and oleic acid (OA) were evaluated against pathogenic P. aeruginosa NG4. Biofilm biomass was quantified by crystal violet staining. The swarming and swimming motility were assessed on semi-solid agar, and planktonic growth was measured spectrophotometrically. Confocal laser scanning microscopy (CLSM) was used to visualise the biofilm structure. Both IBA and OA exhibited potent antibiofilm activity at low concentrations, with ~ 50% and ~ 54% inhibition, respectively, at 5 µg/mL, without affecting planktonic growth. Higher concentrations impaired bacterial proliferation, and both agents significantly reduced swarming motility, with OA exerting slightly greater inhibition. A significant breakdown of biofilm architecture was evident in CLSM images following treatment. To the best of our knowledge, this is the first study to demonstrate that IBA and OA exert significant antibiofilm and anti-motility effects against P. aeruginosa NG4 at low concentrations under the conditions tested, providing a foundation for future mechanistic and biological investigations.
Indexed as
Identifiers
42517933What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.